Clinical experience with MultiHance in CNS imaging

European Radiology

Volumn 13, Issue SUPPL. 3, 2003, Pages

  Essig, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIC ACID; GADOTERIDOL; GADOVERSETAMIDE;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRIORITY JOURNAL;

CENTRAL NERVOUS SYSTEM DISEASES; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY;

EID: 0347917118     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-003-0001-5     Document Type: Article

References (36)

1. Brant-Zawadski M, Norman D, Newton TH (1984) Magnetic resonance imaging of the brain: the optimal screening technique. Radiology 152:71-77
2. Muroff LR, Runge VM (1995) The use of MR contrast in neoplastic disease of the brain. Top Magn Reson Imaging 7:137-157
3. Edelmann RR, Hesselink JR, Zlatkin MB (1996): Clinical magnetic resonance imaging. Second edition. W.B. Saunders
4. Essig M, Knopp MV, Schoenberg SO, Hawighorst H, Wenz F, Debus J, van Kaick G (1999) Contrast enhanced fast fluid-attenuated inversion-recovery (FLAIR) MR imaging in the assessment of primary glial tumors and brain metastases. Radiology 210:551-557
5. Erickson BJ, Campeau NG, Schreiner SA, Buckner JC, O'Neill BP, O'Fallon JR (2002) Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas. J Neurooncol 60:25-29.
6. Schneider G, Kirchin MA, Pirovano G et al (2001) Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation. J Magn Reson Imaging 14:525-539
7. de Haën C, Cabrini M, Akhnana L, Ratti D, Calabi L, Gozzini L (1999) Gadobenate dimeglumine 0.5 M solution for injection (MultiHance): Pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23 (suppl. 1):161-168.
8. Yuh WTC, Fisher DJ, Engelken JD et al (1991) MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180:485-491
9. Myhr G, Rinck PA, Børseth A (1992) Gadodiamide injection and gadopentetate dimeglumine: a double-blind study in MR imaging of the CNS. Acta Radiologica 33:405-409
10. Valk J, Algra PR, Hazenberg CJ, Slooff WBM, Slavand MG (1993) A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system. Neuroradiology 35:173-177
11. Oudkerk M, Sijens PE, van Beek EJ, Kuijpers TJ (1995) Safety and efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. Invest Radiol 30:75-78
12. Greco A, Parker JR, Ratcliffe CG, Kirchin MA, McNamara MT (2001) Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions. Australas Radiol 45:457-63
13. Cavagna FM, Maggioni F, Castelli PM et al (1997) Gd chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780-796
14. Knopp MV, Schoenberg SO, Rehm C et al (2002) Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography: Phase I studies. Invest Radiol 37:706-715
15. Rosati G, Pirovano G, Spinazzi A (1994). Interim results of phase II clinical testing of gadobenate dimeglumine. Invest Radiol 29: S183-S185
16. Ruscalleda J, Kirchin MA, La Noce A, Pirovano G, Spinazzi A (1999) Multihance in the assessment of intracranial tumors: results of phase II clinical studies. J Comput Assist Tomogr 23 (Suppl. 1): S19-S27
17. Balériaux D, Colosimo C, Ruscalleda J, et al (2002) Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Neuroradiology 44:191-203
18. Schneider G, Kirchin MA, Pirovano G, et al (2001) Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation. J Magn Reson Imaging 14:525-539
19. Runge VM, Armstrong MR, Barr RG et al (2001) A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology. Invest Radiol 36:65-71
20. Runge V, Parker JR, Donovan M (2002) Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain. Invest Radiol 37:269-280
21. Colosimo C, Ruscalleda J, Korves M, et al (2001) Detection of intracranial metastases: a multi-center, intra-patient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dose. Invest Radiol 36:72-81
22. Essig M, Hartmann M, Lodemann KP, Janson O, Runge V, Knopp MV (2001) Vergleich des Kontrastverhaltens von Gd-BOPTA und Gd-DTPA bei intraaxialen Hirntumoren: Eine doppelblinde randomisierte intraindividuelle Vergleichsstudie. Radiologe 41:1063-1071 [in German]
23. Knopp MV, Runge VM, Essig M, et al (2003) Primary and secondary brain tumors: a bicentric intra-individual crossover comparison of gadobenate dimeglumine with gadopentetate dimeglumine for lesion enhancement. Radiology (in press)
24. Colosimo C, Knopp MV, Barreau X, et al (2003) Is increased contrast agent relaxivity beneficial for enhanced MR imaging of brain tumors: blinded intraindividual comparison of Gd-BOPTA and Gd-DOTA. Neuroradiology (in press)
25. Bednarz G, Downes B, Werner-Wasik M. Rosenwasser RH (2000) Combining stereotactic angiography and 3D time-of-flight magnetic resonance angiography in treatment planning for arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 46:1149-1154
26. Ikawa F, Sumida M, Uozumi T, et. al (1995) Demonstration of the venous systems with gadolinium-enhanced three-dimensional phase-contrast MR venography. Neurosurg Rev 18:101-107
27. Essig M, Reichenbach J, Schad LR, Schönberg SO, Knopp MV, Kaiser WA (1999) High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imag 17:1417-1425
28. Schlemmer H-P, Heß T, Debus J, Knopp MV, Schad LR, Engenhart R (1994) TOF-MR-Angiographie bei strahlentherapeutisch behandelten zerebralen arteriovenösen Malformationen. Radiologe 34:447-453
29. Stevenson J, Knopp EA, Litt AW (1995) MP-RAGE Subtraction venography: A new technique. J Magn Res Imag 5:239-241
30. Sardanelli F, Zandrino F, Parodi RC, De Caro G (1999) MR Angiography of internal carotid arteries: breath-hold Gd-enhanced 3D fast imaging with steady-state precession versus unenhanced 2D and 3D time-of-flight techniques. J Comput Assist Tomogr 23:208-215
31. Duran M, Schoenberg SO, Yuh WTC, Knopp MV, van Kaick G, Essig M (2002) Cerebral arteriovenous malformations: morphologic evaluation by ultrashort 3D gadolinium-enhanced MR angiography. Eur Radiol 12:2957-2964
32. Balériaux DL, Metens T, Neugroschl C, Sadeghi N, David P, Rodesch G (2002) Improved dynamic MRDSA of brain AVM with gadobenate dimeglumine (Gd-BOPTA). Presented at 88th Scientific Assembly and Annual meeting of the Radiological Society of North America, Chicago, Illinois, USA. Radiology 225 (Suppl) p.282 (abstract)
33. Schaefer PW, Hunter GJ, He J, Hamberg LM, Sorensen AG, Schwamm LH, Koroshetz WJ, Gonzalez RG (2002) Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. Am J Neuroradiol 23:1785-1794
34. Essig M, Wenz F, Scholdei R, Bruening R, Berchtenbreiter C, Meurer M, Knopp MV (2002) Effect of contrast media dosage and contrast media extravasation on dynamic susceptibility-contrast enhanced dynamic echo-planar imaging of cerebral gliomas. Acta Radiol 43:354-359
35. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G (2001) Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. Am J Neuroradiol 22:1030-1036
36. Essig M, Lodemann KP, LeHuu M, Schonberg SO, Hubener M, Van Kaick G (2002) Comparison of MultiHance" and Gadovist" for cerebral MR perfusion imaging in healthy volunteers. Radiologe 42:909-915